1. 134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study. (April 2020) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Forrest Gordon, Mark; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study. (April 2020) Authors: Fernandez, Hubert H.; Barkay, Hadas; Hauser, Robert A.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders. (April 2022) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. (April 2021) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-Term Efficacy and Safety of Deutetrabenazine in Patients with Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use. (April 2022) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗